News

News stories

close up image of mitochondria in fibroblasts
Mitochondria in fibroblasts

World Alzheimer’s Month - Understanding the mitochondria

As part of World Alzheimer’s Month, we’re shining a light on the Mortiboys Lab, a lab dedicated to understanding the mitochondria in neurodegenerative diseases.
Professor Oliver Bandmann

Professor Oliver Bandmann honoured for Parkinson’s research

Professor Oliver Bandmann, Co-Director of the Neuroscience Institute has been awarded the 2024 Tom Isaacs Award in recognition of his outstanding Parkinson’s research.
brain scan

Ongoing dementia studies at the Neuroscience Institute

Our dementia research is internationally recognised and brings together clinicians, scientists and researchers from multiple disciplines. As part of World Alzheimer’s Month, we’re shining a spotlight on some of our ongoing studies.
image of astrocytes under microscope

Research study identifies a new therapeutic target for Alzheimer’s disease

Research from the Neuroscience Institute identifies the impact of a reduction in astrocytes in the hexokinase 1 (HK1) enzyme in Alzheimer’s disease, paving a new pathway for potential treatments.
Head up collar

Sheffield-developed HeadUp Collar wins global award for patient driven research

A cross-organisation collaboration led by The University of Sheffield has been awarded for the development of an innovative neck collar designed for people affected by MND; the first ever global award celebrating excellence in patient engagement.
DNA molecule illustration

BenevolentAI progresses BEN-34712 for the potential treatment of ALS into IND-enabling studies

Benevolent AI, working alongside University of Sheffield researchers have announced the successful delivery of its pre-clincal candidate, BEN-34712, for the potential treatment of motor neurone disease.

The exterior of the SITraN building at the University of Sheffield

Sheffield Support Group hosts Parkinson's information day

A free Parkinson’s event, organised by the Sheffield Support Group of Parkinson’s UK, in conjunction with The University of Sheffield and Sheffield Biomedical Research Centre will take place on Saturday 3rd June. Early registration advised.

| Published by The Star
Lumbar Puncture - treatment for MND
NIHR Sheffield Biomedical Research Centre

FDA approves drug which helps to slow progression of rare form of MND

The Food and Drug Administration (FDA) in the US has authorised the first approved drug for a rare form of motor neurone disease (MND) based on the results of a Phase 3 clinical trial completed at the University of Sheffield.
The Queen opening SITraN with Dame Pam Shaw

Motor neurone disease: Sheffield's Dame Pamela Shaw on a life treating a 'devastating' condition

Professor Dame Pamela Shaw has dedicated her life and a remarkable career to investigating and treating Motor Neuron Disease (MND). Features in today’s Yorkshire Post, she discusses why she is optimistic that there will one day be a cure.

| Published by The Yorkshire Post